The Added Value of In-Hospital Tracking of the Efficacy of Decongestion Therapy and Prognostic Value of a Wearable Thoracic Impedance Sensor in Acutely Decompensated Heart Failure With Volume Overload: Prospective Cohort Study.
Christophe J P SmeetsSeulki LeeWillemijn GroenendaalGabriel SquillaceJulie VrankenHélène De CannièreChris Van HoofLars GrietenWilfried MullensPetra NijstPieter M VandervoortPublished in: JMIR cardio (2020)
The wearable bioimpedance device was able to track changes in fluid status during hospitalization and is a convenient method to assess the efficacy of decongestion therapy during hospitalization. Patients who do not show an improvement in thoracic impedance tend to have worse clinical outcomes, indicating the potential use of thoracic impedance as a prognostic parameter.